Select Medical Holdings Beheer

Beheer criteriumcontroles 1/4

De CEO Select Medical Holdings is David Chernow, benoemd in Jan2014, heeft een ambtstermijn van 10.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 10.71M, bestaande uit 9.3% salaris en 90.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.73% van de aandelen van het bedrijf, ter waarde € 35.79M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.1 jaar en 14.5 jaar.

Belangrijke informatie

David Chernow

Algemeen directeur

US$10.7m

Totale compensatie

Percentage CEO-salaris	9.3%
Dienstverband CEO	10.8yrs
Eigendom CEO	0.7%
Management gemiddelde ambtstermijn	1.1yrs
Gemiddelde ambtstermijn bestuur	14.5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is David Chernow's beloning veranderd ten opzichte van Select Medical Holdings's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	US$266m
Jun 30 2024	n/a	n/a	US$259m
Mar 31 2024	n/a	n/a	US$260m
Dec 31 2023	US$11m	US$995k	US$235m
Sep 30 2023	n/a	n/a	US$217m
Jun 30 2023	n/a	n/a	US$196m
Mar 31 2023	n/a	n/a	US$174m
Dec 31 2022	US$9m	US$995k	US$153m
Sep 30 2022	n/a	n/a	US$175m
Jun 30 2022	n/a	n/a	US$223m
Mar 31 2022	n/a	n/a	US$329m
Dec 31 2021	US$12m	US$995k	US$389m
Sep 30 2021	n/a	n/a	US$415m
Jun 30 2021	n/a	n/a	US$415m
Mar 31 2021	n/a	n/a	US$306m
Dec 31 2020	US$8m	US$995k	US$250m
Sep 30 2020	n/a	n/a	US$206m
Jun 30 2020	n/a	n/a	US$162m
Mar 31 2020	n/a	n/a	US$155m
Dec 31 2019	US$8m	US$995k	US$143m
Sep 30 2019	n/a	n/a	US$136m
Jun 30 2019	n/a	n/a	US$138m
Mar 31 2019	n/a	n/a	US$140m
Dec 31 2018	US$8m	US$995k	US$133m
Sep 30 2018	n/a	n/a	US$207m
Jun 30 2018	n/a	n/a	US$193m
Mar 31 2018	n/a	n/a	US$189m
Dec 31 2017	US$7m	US$984k	US$171m

Compensatie versus markt: De totale vergoeding ($USD 10.71M ) David } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 3.59M ).

Compensatie versus inkomsten: De vergoeding van David is het afgelopen jaar met meer dan 20% gestegen.

CEO

David Chernow (67 yo)

10.8yrs

Tenure

US$10,706,265

Compensatie

Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Robert Ortenzio	Co-Founder & Executive Chairman	19.8yrs	US$10.77m	6.94% € 341.0m
David Chernow	Chief Executive Officer	10.8yrs	US$10.71m	0.73% € 35.8m
Michael Malatesta	Executive VP & CFO	1.1yrs	US$1.53m	0.13% € 6.5m
Michael Tarvin	Senior Executive VP	27.8yrs	US$4.44m	0.34% € 16.6m
Martin Jackson	Senior Executive Vice President of Strategic Finance & Operations	1.1yrs	US$6.47m	0.99% € 48.5m
John Saich	Co-President	1.1yrs	geen gegevens	0.51% € 25.1m
Thomas Mullin	Co-President	1.1yrs	geen gegevens	0.24% € 12.0m
Christopher Weigl	Senior VP	1.7yrs	geen gegevens	0.027% € 1.3m
Brian Rusignuolo	Executive VP & Chief Information Officer	3.8yrs	geen gegevens	0.23% € 11.5m
Robert Breighner	Senior Vice President of Compliance & Audit	no data	geen gegevens	0.027% € 1.3m
Shelly Eckenroth	Senior VP & Chief Communications	1.1yrs	geen gegevens	geen gegevens
Mary Lacey	Senior VP & Chief Human Resources Officer	1.1yrs	geen gegevens	geen gegevens

1.1yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van S24 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.1 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Robert Ortenzio	Co-Founder & Executive Chairman	19.8yrs	US$10.77m	6.94% € 341.0m
Russell Carson	Independent Lead Director	19.8yrs	US$384.40k	0.85% € 41.8m
Thomas Scully	Independent Director	20.8yrs	US$383.40k	0.069% € 3.4m
Daniel Thomas	Independent Director	5.3yrs	US$405.80k	0.051% € 2.5m
William Frist	Independent Director	14.5yrs	US$407.83k	0.22% € 10.9m
Marilyn Tavenner	Independent Director	6yrs	US$394.40k	0.042% € 2.1m
James Ely	Independent Director	16yrs	US$414.83k	0.11% € 5.6m
Katherine Davisson	Independent Director	3.6yrs	US$409.80k	0.036% € 1.8m
Parvinderjit Khanuja	Independent Director	3yrs	US$407.83k	0.034% € 1.7m

14.5yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van S24 zijn ervaren en ervaren (gemiddelde ambtstermijn van 14.5 jaar).

Select Medical Holdings Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

Insufficient new directors

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Insider recently sold €268k worth of stock

Independent Director recently sold €308k worth of stock

Recent updates

Insufficient new directors

Investor sentiment improves as stock rises 16%

Third quarter dividend of US$0.13 announced

Third quarter 2024 earnings released: EPS: US$0.43 (vs US$0.38 in 3Q 2023)

Select Medical Holdings Corporation Updates Earnings Guidance for the Year Ending December 31, 2024

Select Medical Holdings Corporation to Report Q3, 2024 Results on Oct 31, 2024

New major risk - Revenue and earnings growth

Second quarter dividend of US$0.13 announced

Second quarter 2024 earnings released: EPS: US$0.60 (vs US$0.61 in 2Q 2023)

Select Medical Holdings Corporation Declares a Cash Dividend, Payable on or About August 30, 2024

Select Medical Holdings Corporation to Report Q2, 2024 Results on Aug 01, 2024

Investor sentiment improves as stock rises 18%

First quarter dividend of US$0.13 announced

New minor risk - Shareholder dilution

First quarter 2024 earnings released: EPS: US$0.75 (vs US$0.56 in 1Q 2023)

Select Medical Reaffirms Earnings Guidance for the Year 2024

Insufficient new directors

Select Medical Holdings Corporation to Report Q1, 2024 Results on May 02, 2024

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Fourth quarter dividend of US$0.13 announced

Full year 2023 earnings released: EPS: US$1.91 (vs US$1.23 in FY 2022)

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2024

Select Medical Holdings Corporation to Report Q4, 2023 Results on Feb 22, 2024

Upcoming dividend of US$0.13 per share at 2.3% yield

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 28, 2023

Third quarter 2023 earnings released: EPS: US$0.38 (vs US$0.21 in 3Q 2022)

Select Medical Holdings Corporation to Report Q3, 2023 Results on Nov 02, 2023

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or about September 1, 2023

Second quarter 2023 earnings released: EPS: US$0.61 (vs US$0.43 in 2Q 2022)

Select Medical Holdings Corporation Provides Earnings Guidance for the Second Quarter Ended June 30, 2023

Select Medical Holdings Corporation to Report Q2, 2023 Results on Aug 03, 2023

Select Medical Holdings Corporation(NYSE:SEM) dropped from Russell Small Cap Comp Value Index

Insider recently sold €268k worth of stock

Upcoming dividend of US$0.13 per share at 1.7% yield

Select Medical Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of 2023

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About May 31, 2023

First quarter 2023 earnings released: EPS: US$0.56 (vs US$0.37 in 1Q 2022)

Full year 2022 earnings released: EPS: US$1.23 (vs US$2.99 in FY 2021)

Select Medical Holdings Corporation to Report Q4, 2022 Results on Feb 23, 2023

Investor sentiment improved over the past week

Upcoming dividend of US$0.13 per share

Third quarter 2022 earnings released: EPS: US$0.21 (vs US$0.57 in 3Q 2021)

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 29, 2022

Select Medical Holdings Corporation to Report Q3, 2022 Results on Nov 03, 2022

Now 21% undervalued

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About September 2, 2022

Now 24% undervalued

Second quarter 2022 earnings released: EPS: US$0.43 (vs US$1.22 in 2Q 2021)

Select Medical Holdings Corporation to Report Q2, 2022 Results on Aug 04, 2022

Upcoming dividend of US$0.13 per share

First quarter 2022 earnings released: EPS: US$0.37 (vs US$0.82 in 1Q 2021)

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or About June 1, 2022

Select Medical Holdings Corporation to Report Q1, 2022 Results on May 05, 2022

Select Medical Holdings Corporation (NYSE:SEM) acquired Six Critical Illness Recovery Hospitals.

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Select Medical Holdings Corporation Provides Revenue Guidance for the Year 2022

Investor sentiment deteriorated over the past week

Select Medical Holdings Corporation Provides Earnings Guidance for the Year Ended December 31, 2021

Third quarter 2021 earnings released: EPS US$0.57 (vs US$0.57 in 3Q 2020)

Independent Director recently sold €308k worth of stock

Upcoming dividend of US$0.13 per share

Second quarter 2021 earnings released: EPS US$1.22 (vs US$0.39 in 2Q 2020)

Select Medical Holdings Corporation Provides Earnings Outlook for the Full Year 2021

Select Medical Holdings Corporation (NYSE:SEM) completed the acquisition of AcuityHealthcare, LP.

Select Medical Holdings Corporation (NYSE:SEM) and Northwest Healthcare agreed to acquire Curahealth Tucson from Curahealth, LLC.

Independent Director recently sold €349k worth of stock

Insider recently sold €163k worth of stock

Insider recently sold €154k worth of stock